Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • INBRIJA Carton and Inhaler

    New Parkinson's Drug Comes to Market after Early Investment from The Michael J. Fox Foundation

    Our Foundation funded early trials of Inbrija, an inhaled levodopa powder approved last week for "off" episodes with Parkinson's disease.
    Learn more
  • Beakers with MJFF logos

    Inhaled Levodopa for 'Off' Time Approved by FDA

    The FDA approved the formulation, called Inbrija, for intermittent treatment of "off" episodes in people with Parkinson's disease treated with carbidopa/levodopa.
    Learn more
  • Lab Equipment

    Research Roundup: Trials Stepping Forward to Potentially Slow Disease and Ease Symptoms

    Several trials recently took steps forward to advance new therapies that could slow or stop Parkinson's progression and treat movement and non-movement symptoms.
    Learn more
  • Testing Materials

    PPMI Dispatch: The Study Enters a New Phase

    The study completed enrollment and met the ambitious goal of enrolling 1,400 participants, including 600 with rare genetic mutations.
    Learn more
  • Researcher-computer

    Harnessing AI for Parkinson's Research

    MJFF and IBM announced a partnership using artificial intelligence to develop a model for Parkinson's.
    Learn more
  • 2018 in Review Research Progress

    2018 in Review, 2019 in Focus

    Read highlights and download our 2018 in Review/2019 in Focus booklet.
    Learn more
  • Researchers talking with patients

    Parkinson's Inosine Trial Ending Early

    An interim analysis concluded that the SURE-PD3 trial is unlikely to determine that inosine can slow Parkinson's progression. The trial therefore is ending earlier than planned.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.